fda approvals in urothelial cancer and prostate cancer, priority review in crc, and more
Published 4 years ago • 106 plays • Length 13:01
Download video MP4
Download video MP3
Similar videos
-
7:27
fda approvals in prostate cancer and endometrial cancer, and priority review in urothelial cancer
-
6:59
fda approval in nsclc, priority review in bladder cancer, mbcc highlights, and more
-
10:25
priority reviews in prostate and bladder cancer, nccn crc guidelines update, and more
-
6:58
fda approvals in nsclc and soft tissue sarcoma, priority review in bladder cancer, and more
-
6:13
fda approval in carcinoid syndrome diarrhea, priority reviews in bladder cancer and nsclc, and more
-
9:10
fda approvals in urothelial cancer and gist, promising data in urothelial carcinoma, and more
-
0:31
preview: fda approvals in nsclc and soft tissue sarcoma, priority review in bladder cancer, and more
-
5:32
fda approval and 2 priority reviews in bladder cancer, and asco's cancer advance of the year
-
9:27
fda approval in bladder cancer, breakthrough therapy designation in dlbcl, and more
-
8:30
fda approvals in bladder cancer, nsclc, aml, hcc, and a breakthrough designation in nsclc
-
1:10
dr. steinberg on the fda approval of atezolizumab in bladder cancer
-
9:07
fda approvals in breast cancer and bladder cancer and phase iii data with larotrectinib
-
7:05
the fda approval of atezolizumab in bladder cancer
-
8:43
fda approvals in bladder cancer and nsclc, and 2019 elcc highlights
-
7:39
fda approvals in all, ovarian cancer, priority review in ctcl, and snda submitted in rcc
-
3:19
fda approval of durvalumab for advanced bladder cancer
-
9:41
fda approvals in follicular lymphoma and prostate cancer, biosimilar is granted approval, and more
-
0:55
dr. siefker-radtke on fda approval of frontline atezolizumab in bladder cancer
-
7:21
fda approval in breast cancer, breakthrough designations in aml and bladder cancer, and more
Clip.africa.com - Privacy-policy